ABSTRACT
INTRODUCTION
As more and more gene expression data become available, there is a great need to analyse these data beyond the expression profile. Recent publications describe methods of correlating multiple microarray datasets to identify additional genetic information (Choi et al., 2003; Ghosh et al., 2003; Smid et al., 2003) . The function of a gene also provides a valuable extra dimension in the analysis of gene expression studies. In order to identify the less general biological processes from long lists of names of genes with altered expression, we needed an automated retrieval of functional * To whom correspondence should be addressed.
information of all genes measured in expression profiling studies involving microarrays or serial analysis of gene expression (SAGE) (Velculescu et al., 1995; Duggan et al., 1999; Lipshutz et al., 1999; Brown and Botstein, 1999) . We used the ontologies made available by the Gene Ontology (GO) consortium (Ashburner et al., 2000; Gene Ontology Consortium, 2001; Harris et al., 2004) to construct a functional categorization of gene expression data. The GO consortium aims to compose a structured terminology describing various aspects of biology shared by all living forms to annotate genetic data in a consistent way. Three ontology files are offered, biological process, molecular function and cellular component. GO is structured in a hierarchical tree in the form of a directed acyclic graph. This allows for a 'child' term to have multiple 'parents' where all paths from the child-term to its higher level parent(s) must be 'true'. The GO structure enables researchers to connect their protein and/or genetic data to a GO-term, which allows a functional analysis on the abovementioned areas of biology. Although some tools are available for linking microarray expression data to GO in an automated way (selected examples: Khatri et al., 2002; Doniger et al., 2003; Zeeberg et al., 2003; Al-Shahrour et al., 2004; Robinson et al., 2004; Zhang et al., 2004) , these tools require a predefined expression threshold to select the genes for functional evaluation. Basically, selected genes are checked for overrepresentation of a particular process compared with the unselected gene set. Furthermore, to our knowledge no software application existed linking SAGE data to GO. Here we report the development of an application, named GO-Mapper, to automatically compare any number of expression datasets. The GO-Mapper uses the actual measured gene expression level (intensity, ratio or tag-count) to weigh a GO-term and the output can be filtered for the GO-terms most representative of gene expression changes in the experiment under study. The aggregate of representative GO-terms shapes the functional profile of the experiment. Comparing multiple experiments may point to new hypothesis based on correlated GO-terms.
MATERIALS AND METHODS

Processing and linking data
Linking of human genes was accomplished by connecting Unigene Hs numbers to GO by using Loc2UG (ftp://ftp. ncbi.nih.gov/refseq/LocusLink), human.xrefs (ftp://ftp.ebi.ac. uk/pub/databases/GO/goa/HUMAN) and gene.associations. goa.human (ftp://ftp.geneontology.org/pub/go). Using IPI numbers as a linking pin a total of 11 927 Unigene Hs numbers could be linked to at least one GO-number (Unigene build #160, GO data from 27 August 2003). Using Loc2UG (see above) and a text-file linking Locuslink to GO number (Loc2go, ftp://ftp.ncbi.nih.gov/refseq/LocusLink) genes of other (non-human) organisms were linked. Locuslink provides data for human, mouse, rat, zebrafish and fruitfly. Yeast data were obtained from ftp://genome-ftp. stanford.edu/pub/yeast/data_download/literature_curation/ gene_association.sgd; this file holds the yeast identifier SGDID and the GO-association. Subsequently, we downloaded and processed the three ontologies; all types of evidence codes used in the GO annotation were included (ftp://ftp.geneontology.org/pub/go). Perl scripts were developed to combine these files. Genes are linked to the GO-term derived from the abovementioned annotation files, and to all the parental GO-terms (see Results section and Fig. 1 ). The 'true path' rule of the GO-structure is thus conserved. In the final output file, Unigene cluster numbers are automatically substituted for the appropriate gene names where possible.
Microarray and SAGE data
We used in house microarray data to develop the GO-Mapper. The dataset on about 9000 genes (Incyte Genomics, UniGEMV2) was derived from the human breast cancer cellline ZR-75-1 (used as reference), stimulated with growth factors or estrogen, or from cells transfected with the BCAR1 or BCAR3 genes (L.C.J. Dorssers, T. van Agthoven, A. Brinkman, J. Veldscholte, M. Smid, K.J. Dechering, submitted for publication). Data were collected from dye-swapped experiments, combined and evaluated with the Rosetta Resolver software (v3.2) using an Incyte/UniGEM error model (Rosetta Inpharmics Inc., Kirkland, WA).
We downloaded the microarray dataset from http://www. pnas.org and the SAGE dataset from http://www.ncbi.nlm.nih. gov/geo (accession codes GSM5435 and GSM5436). For the microarray dataset, 2-log ratios were calculated for the 539 genes from Table 3 , selected according to the criteria as presented by Sesto et al. (2002) . In these microarray experiments, RNA from UV-B irradiated human keratinocytes was analysed using normal keratinocytes as a reference. The SAGE dataset consists of two libraries of mouse adult and foetal testis. Only tags were provided that were present in both the libraries and had more than 12 counts per million (O'Shaughnessy et al., 2003) . GenBank accession codes from these datasets were linked to Unigene numbers.
GO-Mapper
The GO-Mapper application reads an input file containing the gene to GO links, the GO tree and the gene names. The user is prompted for a text file containing the expression data wherein the genes are listed by their Unigene cluster number (in the case of yeast data, the SGDID). The cluster number/SGDID is used as a unique identifier to link the input files. Multiple measurements of the same gene are allowed and are taken into account in the calculations. For every experiment, the expression data of the genes associated with the GO-terms are linked. In the case of microarray data, the absolute log ratio of a gene is used to score each associated term. If for example 10 genes are associated with a term, the absolute log ratios of these 10 genes were averaged, excluding missing values, but including multiple measurements of the same gene present on the array (Fig. 1 ). In case the expression level of a gene is above a userdefined upper limit, this level is equalized to the upper limit. This prohibits a high gene expression (log) ratio dominating the weight of a term. The Expression Quotient (EQ) is then calculated as the quotient of the average expression ratio of the genes associated with a GO-term and the average expression ratio of all genes measured on the array. To determine whether the EQ is statistically significant, the unique GO-terms were grouped according to the number of genes associated. Some groups were pooled to suit a Gaussian distribution. The EQs of the GO-terms were log-transformed and the mean and SD per group determined and plotted (Supplementary information Figure 5 ). The EQ of interest was checked if it was outside the range of mean ± 1.96SD (P < 0.05) or mean ± 2.58SD (P < 0.01). When dealing with SAGE data, the (normalized) tag-count is used to weigh each associated term. In this case, applying a lower limit of tag-counts may be desirable. The GO-Mapper generates a tab delimited text file, which can be easily analysed in a spreadsheet program. Data presented here is analysed using Microsoft Excel. A schematic representation of the output of GO-Mapper is depicted in Figure 1 . The output also displays some information about the input data (including the number of genes analysed, the total score and total number of genes per array). We applied additional filtering and visual formatting of the EQs to simplify the discovery of potential interesting GO-terms.
Availability
The GO-Mapper application (the Perl script as well as the Windows executable) is free of charge available from our website (http://www.erasmusmc.nl/gatcplatform). In addition, information about data input formats and our Perl scripts for combining the various source files will also be made available on this website. Genes are linked to GO-terms as explained in the text. The EQ is calculated as indicated (ave.exp. indicates average expression). An example of the output file of the GO-Mapper is shown at the bottom. The GO-type can be P, F or C for biological process, molecular function or cellular component, respectively. The gene names are listed alphabetically and follow the Locuslink convention. The column ' measured' provides the total number of data points maximally available for the analysis. The 'measured' column holds the number of actual data for the particular experiment of which the average is calculated; multiple measurements of the same gene and/or missing data are taken into account. The EQ column heading is normally substituted for the experiment name as read from the input expression data file. GO-terms are tab-indented to indicate child terms.
RESULTS
GO-Mapper design
The main purpose of the GO-Mapper was to automatically link genes to GO terms and more importantly, to use the measured gene expression level as a weight to evaluate these GO-terms. The general procedure for expression data derived from dual colour microarray experiments is outlined in Figure 1 . Gene expression ratio data are linked to the GO data using the Unigene cluster number as a linking pin. We developed a method for optimal retrieval of the information stored in the tree structure of GO. In the GO database, a gene is associated to one or more distinct GO-terms. In addition, the path to each GO-term also contains valuable information. The GO-Mapper directly links genes to the associated GO-terms and to all of its parental terms, thereby achieving a higher information density.
The additional value of this procedure is that genes associated with different terms within the same tree in GO will converge on the common parental term of these genes and to all of its parents. For example, the middle panel of Figure 1 shows that genes 4-10 are directly linked to GO-term #1, as indicated by [link] . The child term of GO-term #1 is GO-term #2, while GO-term #3 is a child term of GO-term #2. Each child term is directly linked with other genes. Genes 1, 2 and 3 are part of the same GO-tree and therefore associated with GO-term #1, as indicated by [child] . After linking all genes to GO-terms, we calculated the average of the absolute expression ratios of the genes associated with a GO-term and normalized this score to the average absolute expression ratio of all genes measured in the array. We named this the Expression Quotient (EQ). Thus, a GO-term with an EQ of 3 indicates that the genes associated with this term have a three times higher average expression ratio than the average expression ratio of all genes measured in the experiment. An output file is generated which lists the EQ per GO-term, following the hierarchy of GO. In addition, the number and names of the genes associated with each GO-term are listed.
GO-Mapper development
In house microarray experiments on breast cancer cell lines indicated that one of the cell lines (BCAR3) showed subtle changes in expression of a set of genes implicated in glycolysis (L.C.J. Dorssers, T. van Agthoven, A. Brinkman, J. Veldscholte, M. Smid, K.J. Dechering, submitted for publication). This knowledge was used to develop and test the GO-Mapper. In these tests we have focused on the size of the dataset, various options for normalization and expression data quality. When using microarray data, the reported level of up-or downregulation of a gene only reflects the expression of that gene in relation to the reference sample used in the experiment. We have used the absolute expression log ratio in the GO-Mapper procedure. This enables us to link the level of expression change of a gene to a particular process, regardless of the direction of the expression change. In initial experiments, a set of about 2300 genes was used, which exhibited a statistically significant (P < 0.01) difference in expression in at least one out of eight experiments. This set was compared with a dataset that included reliably measured data points of all linked genes (n = 6166) and found that this did not cause major changes in the possibility to identify linkages between sets of genes and particular GO-terms (data not shown). Since the goal is to retrieve as much information as possible, we have continued to use the complete gene set in our GO-Mapper tests. In order to compare the scores of GO-terms across experiments, some sort of normalization was required. GO-term scores i.e. the average expression of the genes associated with specific GO-term, were normalized against the average expression of all genes measured in the experiment. As an alternative, we normalized the average expression of genes associated with a particular GO-term in a manner analogous to northern blotting and Q-PCR analyses. A large set of 'house-keeping' genes was selected, which are associated with the GO-term 'Metabolism' but not with the GO-terms 'Cell death', 'Cell proliferation' or 'Signal transducer activity' and the average expression of these genes (2219 in total) was used for the normalization. As mentioned, one of our cell lines showed a specific connection to glycolysis, so the GO-tree leading to this term was studied; hardly any changes were found in the EQs when using either the normalization of all genes or using the 'house-keeping gene' normalization, and the EQ of the GO-term 'glycolysis' did not change at all. An example of our GO-Mapper output file using normalization of all genes is presented in Figure 2A . The broadly defined term 'metabolism' is associated with a large number (n = 2845, Fig. 2A ) of genes whose average expression is very close to the average expression of all genes measured in all cell lines (an EQ of ∼1). The EQ of the GO-term 'glycolysis' is 3.4 (P < 0.01) in the BCAR3 cell line, so this term is strongly associated with this cell line. This holds true for all the parental terms up to 'alcohol catabolism'. We next checked the expression data of the genes associated with the term 'glycolysis'. Figure 2B confirms that the expression of most of these genes show a coordinated pattern in the BCAR3 cell line. Other BCAR3-specific GO-terms were studied to identify possible subgroups of functions of the genes associated with glycolysis. Among others, the genes associated with the GO-term 'phosphopyruvate hydratase activity' are also found connected to the glycolysis (EQ = 5.4, P < 0.01, asterisks Fig. 2 ). This exemplifies the detailed information that can be extracted from the GO-Mapper results. One important aspect of our analysis is the observation that the child-terms of a specific parent term may differentiate the connection between GO-terms and experiments. An example is the GO-term 'fructose metabolism' which exhibits a connection to BCAR3 cells (EQ = 2.3, P < 0.05). Inspection of the child terms shows that the EQ of 'fructose 6-phosphate metabolism' is 0.4 (P > 0.05). Thus, the four genes associated with this child term are not connected to the particular experiment. In contrast, the expression changes in three genes linked to the child term 'fructose 2,6-bisphosphate metabolism' together with the genes directly associated with the parental term 'fructose metabolism' are associated with BCAR3-transfected cells.
GO-Mapper validation
The GO-Mapper was validated on publicly available microarray and SAGE datasets. Where possible, the GO-Mapper results were compared with the original analysis. The examples discussed here are derived from (i) the dataset from microarray experiments describing the UV-response of human keratinocytes; results were functionally analysed using the GeneCards database (Sesto et al., 2002; Rebhan et al., 1997) and (ii) a SAGE dataset (O'Shaughnessy et al., 2003) of mouse adult and foetal testis. (Eisen et al., 1998) colour representation of expression ratios of the genes associated with 'glycolysis'. Red indicates upregulation, green downregulation, black indicates no change in expression, grey indicates missing data. Expression data are given relative to non-stimulated cells. The asterisks point to genes associated with 'phosphopyruvate hydratase activity'.
The UV response experiment consisted of six microarrays in which gene expression of human keratinocytes was measured after two time-points (4 and 24 h) with each three doses of irradiation. The expression levels were compared to those of control keratinocytes and the ratio data were 2-log formatted. GO-Mapping was performed using an upper limit of 2 (i.e. a difference in expression of 4) and ratios above this level were equalized to this limit. To focus on dose-independent effects (Fig. 3a) we calculated the EQ for each GO-term, i.e. the average EQ of the three different irradiation doses of the early response was divided by the average EQ of the late response. A EQ lower or higher than 1 is indicative for a correlation with a late or early response, respectively. Some results of GO-Mapping of the UV-response dataset are depicted in Figure 3 . Four genes associated with the term 'negative regulation of transcription' at the 20:4 (dose:time) column have a 1.51 times higher average expression than the average expression of the 433 genes measured in that array. The EQ column shows that the average EQ of the early response is more than twice the average EQ of the late response. This agrees with the reported conclusion that transcriptional arrest occurs during early UV-response (Sesto et al., 2002) . Other conclusions of the study, like changes in 'inflammation' and 'protein catabolism' are also supported by our analysis, as shown in Figure 3 . The results of the GO-Mapper and the relevance of the EQ were further validated by assembling a functional profile, which is able to discriminate between the early and late response. The data were filtered for terms with a EQ >2 or <0.5 to obtain response specific GOterms. We noted that a large number of terms meeting these . In addition to the GO-Mapper output, the EQ is calculated as the average EQ of the 4 h time point experiments (early response) divided by the average EQ of the 24 h time point experiments (late response). Grey and black boxes indicate a EQ of ≥2 or ≤0.5, respectively. GO-terms are tab-indented to indicate child terms. Table 1 . Number (and percentage) of unique GO-terms with a EQ ≥2 or ≤0.5
Original dataset
Average of 5 randomizations All 91 (13%) 35 (5 ± 1%) Two genes 48 (7%) 27 (4 ± 1%) Three genes or more 43 (6%) 8 (1 ± 0.4%) selection criteria were associated with only two genes. To assess the possible random nature of the observed associations with GO-terms, we randomized the expression dataset. After GO-Mapping, 694 unique GO-terms were filtered for response specific terms ( EQ of ≥2 or ≤0.5) and counted these GO-terms according to the number of genes associated with it. The results after 5 separate randomisations are listed in Table 1 . After randomisation, 5% of the unique GO-terms showed a EQ ≥2 or ≤0.5 and appear connected to the experiments. Of these terms, the majority (77%) is associated with only two genes. When selecting 3 genes or more to a GO-term, only 8 out of 694 (1%) unique GO-terms appear connected to the experiments by random chance. Based on these observations, the GO-Mapper data of the original dataset was filtered for 3 or more genes to a GO-term and terms were selected for an early or late response ( EQ ≥2 or ≤0.5, respectively). Out of 43 unique GO-terms, 15 terms associated with an early response and 28 terms with a late response. We used the log ratio data of the 95 genes linked to these 43 terms in standard hierarchical clustering. The arrays were clustered into the early and late response groups (supplementary information Figure 6 ). Thus, the GO-Mapper is able to identify functional terms from GO, of which the expression of the associated genes can distinguish the subsets of the microarray experiments. The complete formatted Excel file is available at http://www.erasmusmc.nl/gatcplatform Figure 4 shows excerpts from the analysis done on the SAGE mouse data (O'Shaughnessy et al., 2003) . This experiment consists of two SAGE libraries; one of adult mouse testis and the other of fetal mouse testis. After GO-Mapping (without applying an upper limit), we again performed an additional calculation to quickly identify the major differences. Here, the A/F column shows the EQ of the adult testis divided by the fetal testis EQ per GO-term. Figure 4 shows that the average tag-count of the 168 genes-187 measurementsbelonging to the GO-term 'development' is just over three times the average tag count of all the genes measured in that library. Furthermore, the A/F EQ column shows that this term has a 4.25 higher EQ in adult compared with fetal testis. This points to a strong association of 'development' with the adult mouse testis, which is as expected. Associations between GO-terms for hormone receptors and extracellular matrix components and fetal and adult testis, also mentioned in the study (O'Shaughnessy et al., 2003) , were observed and are shown in Figure 4 . The complete formatted Excel-file can be downloaded from our website (http://www.erasmusmc.nl/gatcplatform).
DISCUSSION
One of the major challenges in high-throughput gene expression studies is to elucidate which biological processes, Fig. 4 . Excerpts of GO-Mapping of the mouse testes development dataset. Column headings are essentially as mentioned in Figure 1 . In addition to the GO-Mapper output, the 'A/F' column is calculated as the EQ of the adult divided by the EQ of the foetal testes. Black and grey boxes indicate a A/F EQ of ≥2 or ≤ 0.5, respectively. GO-terms are tab-indented to indicate child terms. molecular functions or cellular components are related to the experiments under study. We here report a method of linking sets of gene expression data to the gene annotation constructed by the GO consortium. Two novelties form the basis of the GO-Mapper application; (1) Genes are linked to a specific GO-term and to all of its parental terms (as recommended by the GO consortium) and (2) the actual measured expression data of the associated genes are used as a score to weigh the GO-term. For weighing several different genes belonging to a particular GO-term, averaging positive and negative logtransformed ratio data is not informative. A set of genes with opposing directions of expression may have an average close to 0, while their average absolute log ratios may be significantly different from random. It is clear that the direction of the expression change of a particular gene is relevant for the biological process. Thus, inspection of the actual expression profile of GO-term associated genes is necessary to provide detailed insight in the ongoing processes and the role of the individual genes. Another important feature of the application is that the experimenter decides how gene expression data are entered. While log-transformed ratio data may serve well for dual colour experiments with a relevant reference sample, the use of a heterologous reference in a large series of samples may prefer prior mean centring of the gene expression data. For single colour or SAGE expression measurements, (logtransformed) normalized expression levels or mean-centred data may be used in GO-Mapper.
The GO-Mapper procedure and the obtained EQs were validated in various ways. Our in house microarray data were used to audit the GO-Mapper method. We had a priori knowledge that our dataset harboured a cell line with a distinct expression pattern of genes involved in glycolysis. GO-Mapping of our dataset clearly confirmed these findings (Fig. 2) . In these experiments, we did not observe major effects of the type of normalization or the number of genes included. However, using highly selected subsets of genes from expression profiling experiments will certainly affect the EQ values. In these cases, the use of a normalization procedure based on a selected list of 'housekeeping' genes may prevent an underestimation of the term-specific changes. To keep the GO-Mapper program generally applicable, we have chosen to normalize on all genes and recommend the inclusion of as many genes as possible. It should be noted that the GOMapper method is to some degree vulnerable for the 'garbage in, garbage out' paradigm, and that poor quality data should be removed from the dataset whenever possible. To validate the performance of GO-Mapper, two different data sets were selected. The UV-response microarray data set (Sesto et al., 2002) was selected for UV-regulated genes, while the SAGE dataset (mouse adult and fetal testis) was selected for genes of which the normalized tag-count was at least 12 in both libraries (O'Shaughnessy et al., 2003) . We are aware that selected gene lists, which generally are biased towards the experiments under study, may also be biased towards GO-terms.
The UV-response dataset was previously analysed using the GeneCards database (Rebhan et al., 1997) to assign the UV-regulated genes into 23 functional categories. Genes displaying several functions had been assigned to the function for which the gene was best known. In GO-Mapper, we used the complete GO and used all functional associations to the genes (433 out of 539 genes). We could confirm (Fig. 3) many of the previously established functional relations (Sesto et al., 2002) . The different method of assigning functions to genes may account for the fact that not all conclusions drawn by Sesto et al. could be reproduced. For example the COL5A2 gene is assigned to the 'adhesion' category through the use of the GeneCards database (Sesto et al., 2002) , but is not linked to the GO-terms associated with adhesion.
The mouse SAGE dataset was used to investigate the applicability of using this type of data as input for the GO-Mapper.
Some of the conclusions of functional associations mentioned in the original study (O'Shaughnessy et al., 2003) were confirmed (Fig. 4) . Many different GO-terms were associated with the adult or foetal testes libraries as expected, although we rarely found substantial EQs of GO-terms with a large number of genes associated with it. However, as shown in Figure 4 , even the 168 genes associated with a broadly defined term as 'development' still showed a strong association with the adult testis.
The GO-Mapper has been programmed for general use and therefore does not implement calculations as the EQ or the A/F EQ mentioned in this study as a standard output. The main advantages of using a simple text file as output lies in avoiding learning yet another user interface of a program. Furthermore, the text file is easily imported in a spreadsheet program like Excel to perform additional calculations, like the average and CV (coefficient of variation) of the EQ of a GO-term. Also, as we have shown, the wealth of information can easily be managed by applying smart filters while the use of conditional formatting of cells helps with visualising the results. Other visualisation methods are subject of further investigation. In our analyses we have used all available linkages between genes and function within GO, irrespective of their reliability. Using only verified links (excluding gene linkage based on the non-reviewed evidence code 'inferred from electronic annotation') will improve the reliability of the identified processes, but will also lead to loss of information because many more genes on the expression list will lack a functional annotation. We are confident that the ongoing activities of the GO consortium in expanding the gene function databases as well as the validation of the GO annotation will further increase the usefulness and reliability of GO-Mapper. Our GO-Mapper application can perform a functional analysis of a single experiment with a high level of detail. However, the analysis of a large number of experiments on a functional level holds the potential to decipher the most relevant processes.
